Omeros (OMER) Shares Outstanding (2010 - 2026)

Omeros (OMER) posted Shares Outstanding (Entity) of $72.0 million for Q1 2026, little changed sequentially from $71.7 million in Q4 2025, and up 24.0% YoY from $58.1 million in Q1 2025.

Omeros (OMER) Shares Outstanding (2010 - 2026) Analysis & Trends

Omeros has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $72.0 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 24.0% year-over-year to $72.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.0 million (up 24.0% YoY) and the FY2025 annual result came in at $71.7 million, up 23.48% from the prior year.
  • Shares Outstanding (Entity) steadied at $72.0 million in Q1 2026 per OMER's latest filing, from $71.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $72.0 million in Q1 2026 and troughed at $57.9 million in Q1 2024.
  • A 5-year average of $62.6 million and a median of $62.7 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Entity) slipped 7.82% in 2024, then advanced 24.0% in 2026.
  • Over 5 years, Shares Outstanding (Entity) stood at $62.8 million in 2022, then fell by 2.71% to $61.1 million in 2023, then declined by 5.05% to $58.0 million in 2024, then increased by 23.48% to $71.7 million in 2025, then grew by 0.46% to $72.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $72.0 million, $71.7 million, and $70.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.19 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.45 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 445.06 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.61 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Omeros 1.24 Bn 1.24 Bn 27.73 Mn 72.13 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 71.92 Mn
Mar 31, 2026 71.92 Mn
Dec 31, 2025 63.51 Mn
Sep 30, 2025 66.26 Mn
Jun 30, 2025 58.59 Mn
Mar 31, 2025 58.06 Mn
Dec 31, 2024 58.17 Mn
Sep 30, 2024 57.95 Mn
Jun 30, 2024 57.94 Mn
Mar 31, 2024 58.80 Mn
Dec 31, 2023 62.74 Mn
Sep 30, 2023 62.86 Mn
Jun 30, 2023 62.84 Mn
Mar 31, 2023 62.83 Mn
Dec 31, 2022 62.74 Mn
Sep 30, 2022 62.73 Mn
Jun 30, 2022 62.73 Mn
Mar 31, 2022 62.72 Mn
Dec 31, 2021 62.34 Mn
Sep 30, 2021 62.51 Mn